Investment opportunity in luxury real estate devel...
Why Ethereum Could Hit $5,000 in 2026
Uruguay's Finance Minister Shuns Chainsaw for...
65MW Uruguay project reaches financial close
Christie’s International Real Estate Launche...
Mexico, Chile and Uruguay halt poultry imports fro...
Uruguay’s peso tops Big Mac “overvalua...
Uruguay slashes rates by 100bp to 6.5%

BeiGene Brukinsa gets approval in Uruguay to treat certain blood cancers

Published on: Wednesday 27 April 2022

BeiGene (NASDAQ:BGNE) said its medicine Brukinsa was approved in Uruguay to treat adult patients with previously treated mantle cell lymphoma (MCL), relapsed or refractory marginal zone lymphoma ...

News source: https://seekingalpha.com/news/3828582-beigene-brukinsa-gets-approval-in-uruguay-to-treat-certain-blood-cancers

Share this news on: Facebook Twitter

RELATED NEWS

» BeiGene Brukinsa gets approval in Uruguay to treat certain blood cancers

» Trends in the Wine Industry: From Sustainability to Cryptocurrencies

» MercadoLibre, Inc. Reports First Quarter 2022 Financial Results

» Cryptocurrencies: their rise and the best investments

» Ecuador, Uruguay qualify for World Cup in Qatar, with help from Brazil

HEADLINE NEWS

» Falklands' delegation to Uruguay's Prado agriculture trade show
» Where to buy property in Artigas, Uruguay
» Where to buy property in Treinta y Tres, Uruguay
» Man Utd to ‘bid hard’ and make ‘large investment’ in Barca star
» Uruguay is the only full democracy in South America, The Economist says
» The Global South Moves Towards Vaccine Sovereignty
» Pellistri inspires Uruguay, Colombia to miss World Cup
» Watch: Tottenham’s Bentancur lashes home half-volley for Uruguay
» UPM financial statements release 2021: Earnings back to strong pre-pandemic levels, refined completion plan for Uruguay project ready
» PRO MUJER NAMES CARMEN CORREA AS ITS CEO

My Financial News from Uruguay, Cryptocurrencies

BeiGene Brukinsa gets approval in Uruguay to treat certain blood cancers